DOCEBO INC (DCBO.CA) Fundamental Analysis & Valuation

TSX:DCBO • CA25609L1058

Current stock price

23.81 CAD
-0.33 (-1.37%)
Last:

This DCBO.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

8

1. DCBO.CA Profitability Analysis

1.1 Basic Checks

  • DCBO had positive earnings in the past year.
  • In the past year DCBO had a positive cash flow from operations.
  • Of the past 5 years DCBO 4 years were profitable.
  • Of the past 5 years DCBO 4 years had a positive operating cash flow.
DCBO.CA Yearly Net Income VS EBIT VS OCF VS FCFDCBO.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10M -10M 20M 30M

1.2 Ratios

  • With an excellent Return On Assets value of 18.15%, DCBO belongs to the best of the industry, outperforming 92.42% of the companies in the same industry.
  • DCBO has a better Return On Equity (50.63%) than 95.45% of its industry peers.
  • DCBO has a better Return On Invested Capital (25.58%) than 96.97% of its industry peers.
  • DCBO had an Average Return On Invested Capital over the past 3 years of 14.68%. This is in line with the industry average of 12.88%.
  • The 3 year average ROIC (14.68%) for DCBO is below the current ROIC(25.58%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 18.15%
ROE 50.63%
ROIC 25.58%
ROA(3y)11.32%
ROA(5y)6.27%
ROE(3y)34.17%
ROE(5y)19.81%
ROIC(3y)14.68%
ROIC(5y)N/A
DCBO.CA Yearly ROA, ROE, ROICDCBO.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100 200

1.3 Margins

  • With an excellent Profit Margin value of 15.46%, DCBO belongs to the best of the industry, outperforming 86.36% of the companies in the same industry.
  • In the last couple of years the Profit Margin of DCBO has grown nicely.
  • Looking at the Operating Margin, with a value of 12.13%, DCBO is in the better half of the industry, outperforming 72.73% of the companies in the same industry.
  • Looking at the Gross Margin, with a value of 80.42%, DCBO belongs to the top of the industry, outperforming 83.33% of the companies in the same industry.
  • In the last couple of years the Gross Margin of DCBO has remained more or less at the same level.
Industry RankSector Rank
OM 12.13%
PM (TTM) 15.46%
GM 80.42%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y46.55%
PM growth 5YN/A
GM growth 3Y0%
GM growth 5Y-0.34%
DCBO.CA Yearly Profit, Operating, Gross MarginsDCBO.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 -40 60 80

8

2. DCBO.CA Health Analysis

2.1 Basic Checks

  • DCBO has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
  • DCBO has less shares outstanding than it did 1 year ago.
  • The number of shares outstanding for DCBO has been reduced compared to 5 years ago.
  • Compared to 1 year ago, DCBO has a worse debt to assets ratio.
DCBO.CA Yearly Shares OutstandingDCBO.CA Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M
DCBO.CA Yearly Total Debt VS Total AssetsDCBO.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M

2.2 Solvency

  • DCBO has an Altman-Z score of 2.79. This is not the best score and indicates that DCBO is in the grey zone with still only limited risk for bankruptcy at the moment.
  • The Altman-Z score of DCBO (2.79) is better than 65.15% of its industry peers.
  • The Debt to FCF ratio of DCBO is 0.09, which is an excellent value as it means it would take DCBO, only 0.09 years of fcf income to pay off all of its debts.
  • DCBO has a Debt to FCF ratio of 0.09. This is amongst the best in the industry. DCBO outperforms 90.91% of its industry peers.
  • DCBO has a Debt/Equity ratio of 0.03. This is a healthy value indicating a solid balance between debt and equity.
  • The Debt to Equity ratio of DCBO (0.03) is better than 72.73% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF 0.09
Altman-Z 2.79
ROIC/WACC2.57
WACC9.96%
DCBO.CA Yearly LT Debt VS Equity VS FCFDCBO.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M 100M 150M 200M

2.3 Liquidity

  • DCBO has a Current Ratio of 1.22. This is a normal value and indicates that DCBO is financially healthy and should not expect problems in meeting its short term obligations.
  • DCBO has a Current ratio of 1.22. This is comparable to the rest of the industry: DCBO outperforms 56.06% of its industry peers.
  • DCBO has a Quick Ratio of 1.22. This is a normal value and indicates that DCBO is financially healthy and should not expect problems in meeting its short term obligations.
  • DCBO has a Quick ratio of 1.22. This is comparable to the rest of the industry: DCBO outperforms 56.06% of its industry peers.
  • DCBO does not score too well on the current and quick ratio evaluation. However, as it has excellent solvency and profitability, these ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
Industry RankSector Rank
Current Ratio 1.22
Quick Ratio 1.22
DCBO.CA Yearly Current Assets VS Current LiabilitesDCBO.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M

9

3. DCBO.CA Growth Analysis

3.1 Past

  • DCBO shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 56.98%, which is quite impressive.
  • The Earnings Per Share has been growing by 88.99% on average over the past years. This is a very strong growth
  • The Revenue has grown by 11.87% in the past year. This is quite good.
  • DCBO shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 30.99% yearly.
EPS 1Y (TTM)56.98%
EPS 3Y88.99%
EPS 5YN/A
EPS Q2Q%18.42%
Revenue 1Y (TTM)11.87%
Revenue growth 3Y19.31%
Revenue growth 5Y30.99%
Sales Q2Q%10.51%

3.2 Future

  • The Earnings Per Share is expected to grow by 22.29% on average over the next years. This is a very strong growth
  • Based on estimates for the next years, DCBO will show a very strong growth in Revenue. The Revenue will grow by 26.95% on average per year.
EPS Next Y18.91%
EPS Next 2Y18.91%
EPS Next 3Y20.92%
EPS Next 5Y22.29%
Revenue Next Year10.97%
Revenue Next 2Y11.2%
Revenue Next 3Y11.56%
Revenue Next 5Y26.95%

3.3 Evolution

  • The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
DCBO.CA Yearly Revenue VS EstimatesDCBO.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 200M 400M 600M 800M
DCBO.CA Yearly EPS VS EstimatesDCBO.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 1 2 3

8

4. DCBO.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 12.66, DCBO is valued correctly.
  • 84.85% of the companies in the same industry are more expensive than DCBO, based on the Price/Earnings ratio.
  • DCBO is valuated cheaply when we compare the Price/Earnings ratio to 25.60, which is the current average of the S&P500 Index.
  • DCBO is valuated reasonably with a Price/Forward Earnings ratio of 10.66.
  • DCBO's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. DCBO is cheaper than 78.79% of the companies in the same industry.
  • DCBO is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.84, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 12.66
Fwd PE 10.66
DCBO.CA Price Earnings VS Forward Price EarningsDCBO.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of DCBO indicates a somewhat cheap valuation: DCBO is cheaper than 62.12% of the companies listed in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of DCBO indicates a somewhat cheap valuation: DCBO is cheaper than 75.76% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 18.11
EV/EBITDA 12.9
DCBO.CA Per share dataDCBO.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • DCBO has an outstanding profitability rating, which may justify a higher PE ratio.
  • A more expensive valuation may be justified as DCBO's earnings are expected to grow with 20.92% in the coming years.
PEG (NY)0.67
PEG (5Y)N/A
EPS Next 2Y18.91%
EPS Next 3Y20.92%

0

5. DCBO.CA Dividend Analysis

5.1 Amount

  • DCBO does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

DCBO.CA Fundamentals: All Metrics, Ratios and Statistics

DOCEBO INC

TSX:DCBO (4/2/2026, 7:00:00 PM)

23.81

-0.33 (-1.37%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)02-27
Earnings (Next)05-07
Inst Owners32.89%
Inst Owner ChangeN/A
Ins Owners0.4%
Ins Owner ChangeN/A
Market Cap684.78M
Revenue(TTM)242.69M
Net Income(TTM)37.51M
Analysts80
Price Target29.88 (25.49%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)11.78%
Min EPS beat(2)1.01%
Max EPS beat(2)22.55%
EPS beat(4)4
Avg EPS beat(4)19.42%
Min EPS beat(4)1.01%
Max EPS beat(4)28.07%
EPS beat(8)7
Avg EPS beat(8)27.59%
EPS beat(12)10
Avg EPS beat(12)11.91%
EPS beat(16)13
Avg EPS beat(16)101.18%
Revenue beat(2)0
Avg Revenue beat(2)-0.99%
Min Revenue beat(2)-1.11%
Max Revenue beat(2)-0.86%
Revenue beat(4)1
Avg Revenue beat(4)-0.56%
Min Revenue beat(4)-1.61%
Max Revenue beat(4)1.34%
Revenue beat(8)2
Avg Revenue beat(8)-0.54%
Revenue beat(12)2
Avg Revenue beat(12)-0.68%
Revenue beat(16)2
Avg Revenue beat(16)-0.99%
PT rev (1m)-14.77%
PT rev (3m)-21.45%
EPS NQ rev (1m)-1.61%
EPS NQ rev (3m)2.08%
EPS NY rev (1m)0%
EPS NY rev (3m)5.32%
Revenue NQ rev (1m)0.71%
Revenue NQ rev (3m)3.06%
Revenue NY rev (1m)0.32%
Revenue NY rev (3m)3.42%
Valuation
Industry RankSector Rank
PE 12.66
Fwd PE 10.66
P/S 2.03
P/FCF 18.11
P/OCF 17.48
P/B 6.64
P/tB 8.41
EV/EBITDA 12.9
EPS(TTM)1.88
EY7.9%
EPS(NY)2.23
Fwd EY9.38%
FCF(TTM)1.32
FCFY5.52%
OCF(TTM)1.36
OCFY5.72%
SpS11.74
BVpS3.58
TBVpS2.83
PEG (NY)0.67
PEG (5Y)N/A
Graham Number12.31
Profitability
Industry RankSector Rank
ROA 18.15%
ROE 50.63%
ROCE 35.53%
ROIC 25.58%
ROICexc 240.52%
ROICexgc N/A
OM 12.13%
PM (TTM) 15.46%
GM 80.42%
FCFM 11.2%
ROA(3y)11.32%
ROA(5y)6.27%
ROE(3y)34.17%
ROE(5y)19.81%
ROIC(3y)14.68%
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)20.39%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y46.55%
PM growth 5YN/A
GM growth 3Y0%
GM growth 5Y-0.34%
F-Score6
Asset Turnover1.17
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF 0.09
Debt/EBITDA 0.06
Cap/Depr 30.79%
Cap/Sales 0.4%
Interest Coverage 250
Cash Conversion 86.37%
Profit Quality 72.49%
Current Ratio 1.22
Quick Ratio 1.22
Altman-Z 2.79
F-Score6
WACC9.96%
ROIC/WACC2.57
Cap/Depr(3y)29.27%
Cap/Depr(5y)38.17%
Cap/Sales(3y)0.44%
Cap/Sales(5y)0.64%
Profit Quality(3y)239%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)56.98%
EPS 3Y88.99%
EPS 5YN/A
EPS Q2Q%18.42%
EPS Next Y18.91%
EPS Next 2Y18.91%
EPS Next 3Y20.92%
EPS Next 5Y22.29%
Revenue 1Y (TTM)11.87%
Revenue growth 3Y19.31%
Revenue growth 5Y30.99%
Sales Q2Q%10.51%
Revenue Next Year10.97%
Revenue Next 2Y11.2%
Revenue Next 3Y11.56%
Revenue Next 5Y26.95%
EBIT growth 1Y55.67%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year118.64%
EBIT Next 3Y44.38%
EBIT Next 5Y27.18%
FCF growth 1Y-2.9%
FCF growth 3Y182.43%
FCF growth 5Y48.94%
OCF growth 1Y-3.68%
OCF growth 3Y130.92%
OCF growth 5Y40.42%

DOCEBO INC / DCBO.CA Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for DOCEBO INC?

ChartMill assigns a fundamental rating of 8 / 10 to DCBO.CA.


What is the valuation status for DCBO stock?

ChartMill assigns a valuation rating of 8 / 10 to DOCEBO INC (DCBO.CA). This can be considered as Undervalued.


What is the profitability of DCBO stock?

DOCEBO INC (DCBO.CA) has a profitability rating of 8 / 10.


What is the financial health of DOCEBO INC (DCBO.CA) stock?

The financial health rating of DOCEBO INC (DCBO.CA) is 8 / 10.


What is the earnings growth outlook for DOCEBO INC?

The Earnings per Share (EPS) of DOCEBO INC (DCBO.CA) is expected to grow by 18.91% in the next year.